Shareholders meeting

Emcure Ref: EPL/CS/SE/0082/2026 Date: September 21, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai - 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015– Proceedings of the 45th Annual General Meeting of the Members of the Company Pursuant to Regulation 30 read with Clause 13 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the proceedings of the 45th Annual General Meeting (‘AGM’) of the Members of the Company held on Monday, September 21, 2026 at 11:00 a.m. (IST) through Video Conferencing (“VC”)/Other Audio Visual Means (“OAVM”), without the physical presence of Members at a common venue. The same is also being uploaded on the website of the Company, i.e. www.emcure.com You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer ICSI Membership Number: A25687 Encl: As above Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251 Emcure SUMMARY OF PROCEEDINGS OF THE 45TH ANNUAL GENERAL MEETING OF THE MEMBERS OF EMCURE PHARMACEUTICALS LIMITED HELD ON MONDAY, SEPTEMBER 21, 2026 AT 11.00 A.M (IST) THROUGH VIDEO CONFERENCING (“VC”) /OTHER AUDIO VISUAL MEANS (“OAVM”) FACILITY The 45th Annual General Meeting (“AGM”) of the Members of Emcure Pharmaceuticals Limited (“the Company”) was held on Monday, September 21, 2026, through Video Conferencing (“VC”)/ Other Audio-Visual Means (“OAVM”) facility in compliance with the provisions of the Companies Act, 2013 and various circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India, without the physical presence of Members at a common venue. The AGM commenced at 11.00 a.m. (IST) and concluded at 12.23 p.m. (IST) (including time allowed for e-voting at the AGM). The deemed venue for the 45th AGM was the Registered Office of the Company situated at Plot No. P-1 & P2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune – 411 057, Maharashtra. Ms. Amruta Yangalwar, Company Secretary and Compliance Officer, welcomed the Members and introduced the following Board Members and Key Managerial Personnel (KMPs): 1. Mr. Satish Mehta - Managing Director & Chief Executive Officer 2. Mr. Berjis Desai - Chairman of the Company and Stakeholders’ Relationship Committee 3. Mr. Sunil Mehta - Whole-time Director & Chairman of the CSR Committee 4. Mrs. Namita Thapar - Whole-time Director 5. Mr. Samit Mehta - Whole-time Director & Chief Operating Officer 6. Dr. Mukund Gurjar - Whole-time Director 7. Mr. C S Muralidharan - Independent Director & Chairman of the Audit Committee 8. Dr. Shailesh Ayyangar - Independent Director & Chairman of the Risk Management Committee 9. Mr. Vijay Gokhale - Independent Director & Chairman of the Nomination and Remuneration Committee 10. Mr. Raghu Kumar - Independent Director 11. Mr. Tajuddin Shaikh - Chief Financial Officer Ms. Yangalwar informed that Dr. Vidya Yeravdekar, Woman Independent Director was unable to attend the meeting. She further informed that the authorized representatives of M/s. BSR & Co. LLP, Chartered Accountants (Statutory Auditors), M/s. B.M. Sharma & Co., Cost Accountants (Cost Auditors), M/s. SVD & Associates, Company Secretaries (Secretarial Auditors), Mrs. Ashwini Inamdar, Partner of M/s. Mehta & Mehta, Company Secretaries as Scrutiniser appointed for the AGM, had joined the meeting. Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251 Emcure Mr. Berjis Desai, Chairman of the Company and of the Stakeholders’ Relationship Committee, chaired the meeting and, upon confirmation from the Company Secretary and Compliance Officer that the requisite quorum was present, conducted its proceedings. The Chairman then reflected on his association with the Company, its key achievements, and apprised about his stepping down from the Board of the Company. He expressed his gratitude to the Board, Management, employees and stakeholders for their support and wished the Company continued growth and success in the years ahead. Ms. Yangalwar then briefed the Members about the general instructions regarding participation and voting in the meeting: a) the Company has tied up with MUFG Intime India Private Limited to avail the facility of e-voting and for participating in this AGM through video conferencing. b) the remote e-voting facility was open from Friday, September 18, 2026 to Sunday, September 20, 2026. c) electronic voting facility during the AGM was made available for Members who had not exercised their vote through e-voting facility and for thirty minutes post the conclusion of the meeting. d) Mrs. Ashwini Inamdar, Partner of M/s. Mehta & Mehta, Company Secretaries, Mumbai, was appointed as Scrutinizer to supervise the e-voting process and, scrutinize the votes cast through remote e-voting and e-voting facility provided at the meeting. e) the documents and Statutory registers as required under the relevant provisions were kept open for inspection. f) as the meeting was being held through VC, the provisions for appointment of proxies by the Members were not applicable. Mr. Satish Mehta, Managing Director & Chief Executive Officer, briefed the Members on the operations and performance of the Company inter-alia including outlook, strategic priorities and execution, operations and digital transformation. Thereafter, the Chairman took notice of the AGM as circulated earlier to all the Members of the Company, as read. He also informed the Members that, there were no qualifications in the Statutory Auditor's Report and Secretarial Audit Report and the said Reports were considered as read. Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251 Emcure The following items of business, as per the Notice of 45th AGM, were transacted at the meeting: Sr. No. Resolutions Type of Resolution Ordinary Business 1. To receive, consider and adopt: Ordinary a) the Audited Standalone Financial Statements of the Company for the Financial Year ended on March 31, 2026, together with the Report of the Board of Directors and the Auditors thereon; and b) the Audited Consolidated Financial Statements of the Company for the Financial Year ended on March 31, 2026, together with the Report of the Auditors thereon. 2. To declare Final Dividend of INR 3.60/- (Rupees Three and Sixty Paise Ordinary only) per Equity Share of Face Value of INR 10/- each (Rupees Ten only) for the Financial Year ended on March 31, 2026. 3. To appoint Mrs. Namita Thapar (DIN: 05318899) as a Director who Ordinary retires by rotation, and being eligible, offers herself for re-appointment. 4. To consider retirement of Mr. Berjis Desai (DIN: 00153675), Chairman Ordinary and Non-Executive Non-Independent Director. Special Business 5. To ratify Remuneration payable to the Cost Auditor for the Financial Ordinary Year 2026-27. 6. To re-appoint Dr. Mukund Gurjar (DIN: 00026843) as a Whole-time Special Director of the Company. 7. To re-appoint [Showing first 8,000 characters — download PDF for full document]